መነሻ › ትሪፕል-ኔጌቲቭ የደረት ካንሰር › Tennessee › Nashville
በNashville፣ TN ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ 28 ጥናቶች በNashville እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Tennessee Oncology, Nashville
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Sarah Cannon Research Institute, Nashville
- Tennessee Oncology PLLC, Nashville
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Sarah Cannon Research Institute, Nashville
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Sarah Cannon Research Institute (SCRI), Nashville
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Vanderbilt Breast Center at One Hundred Oaks, Nashville
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- SCRI Oncology Partners, Nashville
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Vanderbilt University Medical Center, Nashville
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- SCRI Oncology Partners ( Site 7004), Nashville
- Tennessee Oncology ( Site 0018), Nashville
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- One Oncology - Tennessee Oncology ( Site 0098), Nashville
- SCRI Oncology Partners ( Site 7000), Nashville
- Tennessee Oncology ( Site 0111), Nashville
- እና 1 ተጨማሪ
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- SCRI Oncology Partners ( Site 7005), Nashville
- Nashville General Hospital ( Site 0017), Nashville
- Vanderbilt-Ingram Cancer Center ( Site 0038), Nashville
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Sarah Cannon - Tennessee Oncology, Nashville
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Sarah Cannon Research Institute, Nashville
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Nashville General, Nashville
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Normunity Investigational Site, Nashville
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Vanderbilt University Medical Center, Nashville
SMP-3124LP in Adults With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Sarah Cannon Research Institute at Tennessee Oncology, Nashville
- Tennessee Oncology, Nashville
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Tennessee Oncology, Nashville
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Sarah Cannon Research Institute (SCRI), Nashville
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study of LY4175408 in Participants With Advanced Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Sarah Cannon Research Institute, Nashville
Study of XB010 in Subjects With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- SCRI Oncology Partners, Nashville
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
ተሳታዮችን በመፈለግ ላይደረጃ 1
- SCRI Oncology Partners, Nashville
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
ተሳታዮችን በመፈለግ ላይ
- Vanderbilt-Ingram Cancer Center, Nashville
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Vanderbilt-Ingram Cancer Center, Nashville
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- SCRI Oncology Partners, Nashville
- Tennessee Oncology, PLLC, Nashville
Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Vanderbilt University/Ingram Cancer Center, Nashville
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- SCRI Oncology Partners, Nashville
በሌሎች ከተሞች ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ጥናቶች
- Houston, TX42 ጥናቶች
- New York City, NY31 ጥናቶች
- Los Angeles, CA27 ጥናቶች
- Boston, MA26 ጥናቶች
- San Antonio, TX23 ጥናቶች
- St. Louis, MO21 ጥናቶች
- Arlington, VA20 ጥናቶች
- Atlanta, GA20 ጥናቶች
- Dallas, TX18 ጥናቶች
- Chicago, IL16 ጥናቶች
- Columbus, OH16 ጥናቶች
- Grand Rapids, MI15 ጥናቶች
በNashville ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር97 ጥናቶች
- የጡንቻ ካንሰር81 ጥናቶች
- Metastatic Cancer70 ጥናቶች
- የኮሎሬክታል ካንሰር69 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)65 ጥናቶች
- የእንቁላል ካንሰር49 ጥናቶች
- የፕሮስቴት ካንሰር43 ጥናቶች
- የሳንባ ካንሰር40 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ39 ጥናቶች
- የፓንክሪያስ ካንሰር39 ጥናቶች
- የኤንዶሜትሪየም ካንሰር38 ጥናቶች
- ሜላኖማ33 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።